|
|
|
|
Bio/Data Corporation Launches vW Select - The World's First and Only Complete Ristocetin CoFactor Assay
HORSHAM, Pa., June 30 /PRNewswire/ -- Today, Bio/Data Corporation announced the launch of vW Select(TM), the world's first all-in-one Ristocetin CoFactor Assay.vW Select is the first and only complete assay that measures the functional...
|
|
|
Bio/Data Corporation Launches vW Select(TM) - The World's First and Only Complete Ristocetin CoFactor Assay
vW Select Significantly Reduces Laboratory Variability and Provides Clinicians with More Reliable Test Results HORSHAM, Pa., June 30 /PRNewswire/ -- Today, Bio/Data Corporation announced the launch of vW Select(TM), the world's first all-in...
|
|
|
Bio/Data Corporation Launches vW Select(TM) - The World's First and Only Complete Ristocetin CoFactor Assay
vW Select Significantly Reduces Laboratory Variability and Provides Clinicians with More Reliable Test Results HORSHAM, Pa., June 30 /PRNewswire/ -- Today, Bio/Data Corporation announced the launch of vW Select(TM), the world's first all-in...
|
|
|
Team Uncovers The Molecular Basis For The Regulation Of Blood Clotting
By applying cutting-edge techniques in single-molecule manipulation, researchers at Harvard University have uncovered a fundamental feedback mechanism that the body uses to regulate the clotting of blood.The finding, which could lead to a...
|
|
|
Team Uncovers The Molecular Basis For The Regulation Of Blood Clotting
By applying cutting-edge techniques in single-molecule manipulation, researchers at Harvard University have uncovered a fundamental feedback mechanism that the body uses to regulate the clotting of blood.The finding, which could lead to a...
|
|
|
Researchers solve 'bloodcurdling' mystery
By applying cutting-edge techniques in single-molecule manipulation, researchers at Harvard University have uncovered a fundamental feedback mechanism that the body uses to regulate the clotting of blood.The finding, which could lead to a...
|
|
|
International Panel Of Experts Reaches Consensus On Diagnosis And Treatment Of Bleeding Disorders In Women
Because bleeding from the reproductive tract is a naturally occurring event during menstruation and childbirth, women who exhibit menorrhagia, or excessive bleeding after their menstrual cycle, may have underlying diseases that are...
|
|
|
Researchers Detect Blood-Clotting Mechanism
THURSDAY, June 4 (HealthDay News) -- Ever wonder how your blood miraculously stops flowing and forms a scab after a cut?Researchers have now pinpointed the mechanism down to the molecular level? 'The human body has an incredible ability...
|
|
|
Researchers solve 'bloodcurdling' mystery
By applying cutting-edge techniques in single-molecule manipulation, researchers at Harvard University have uncovered a fundamental feedback mechanism that the body uses to regulate the clotting of blood.The finding, which could lead to a...
|
|
|
New Guidelines To Help Diagnose Bleeding Disorders
Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at Duke University Medical Center.That's about to...
|
|
|
Experts reach consensus on diagnosis and treatment of bleeding disorders in women
Because bleeding from the reproductive tract is a naturally occurring event during menstruation and childbirth, women who exhibit menorrhagia, or excessive bleeding after their menstrual cycle, may have underlying diseases that are...
|
|
|
Women with heavy periods may have an undiagnosed bleeding disorder
According to researchers in the United States many women suffer from bleeding disorders, but are unaware they have one because doctors are not looking for the condition.But that is about to change as an international group of experts have...
|
|
|
Bleeding disorders going undiagnosed; new guidelines to help
DURHAM, NC -- Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at.That's about to change, now that an...
|
|
|
Bleeding disorders going undiagnosed
Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at Duke University Medical Center.That's about to...
|
|
|
Bleeding disorders going undiagnosed; new guidelines to help
DURHAM, NC -- Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at Duke University Medical Center.That...
|
|
|
Bleeding disorders going undiagnosed; new guidelines to help
Nearly one percent of the population suffers from bleeding disorders, yet many women don't know they have one because doctors aren't looking for the condition, according to researchers at Duke University Medical Center.That's about to...
|
|
|
CD34+ cells in maternal placental blood are mainly fetal in origin and express endothelial markers
1UPMC Univ Paris 6, Laboratoire de Physiopathologie du Dveloppement, EA 4053, Paris, France 2INSERM UMR_S893, Saint-Antoine Research Center, Paris, France Correspondence: Dr K Khosrotehrani, MD, PhD, Facult de mdecine Pierre et Marie Curie:...
|
|
|
CD34+ cells in maternal placental blood are mainly fetal in origin and express endothelial markers
Fetal CD34+ cells enter the maternal circulation during pregnancy and may persist for decades.These cells are usually depicted as hematopoietic stem/progenitor cells. Our objective was to further determine the phenotype of fetal...
|
|
|
What is the 5-year cumulative failure rate of global endometrial ablation?
(Click the title below to leave the MDLinx Network and go to the Journal's Website) APCToday, 05/29/09 Bradley LD - 16% of women who underwent global endometrial ablation for AUB needed hysterectomy or repeat ablation for bleeding or pain...
|
|
|
Ablynx Announces That its vWF Nanobody Programme Has Been Granted Orphan Drug Designation and Provides a Busi
- Ablynx [Euronext Brussels: ABLX], a pioneer in the discovery and development of Nanobodies, a novel class of antibody-derived therapeutic proteins, announced today that its anti-thrombotic Nanobody programme targeting von ...
|
|
|
Transient neonatal acquired von Willebrand syndrome due to transplacental transfer of maternal monoclonal anti
Nageswara AA et al.- Although typically a disorder of adults, acquired von Willebrand syndrome is increasingly being recognized in the pediatric population in association with congenital cardiac diseases, certain neoplasia,...
|
|
|
Ablynx bags orphan drug status for nanobody programme from US FDA, EC
Ablynx, a pioneer in the discovery and development of Nanobodies, a novel class of antibody-derived therapeutic proteins, received US Food and Drug Administration (FDA) and the European Commission (EC) orphan drug status for its anti...
|
